FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132415718> ?p ?o ?g. }

• W3132415718 endingPage "2275" @default.
• W3132415718 startingPage "2266" @default.
• W3132415718 abstract "PURPOSE To determine the incidence of serious chronic health conditions among survivors of pediatric Hodgkin lymphoma (HL), compare by era of therapy and by selected cancer therapies, and provide estimates of risks associated with contemporary therapy. METHODS Assessing 2,996 5-year HL survivors in the Childhood Cancer Survivor Study diagnosed from 1970 to 1999, we examined the cumulative incidence of severe to fatal chronic conditions (grades 3-5) using self-report conditions, medically confirmed subsequent malignant neoplasms, and cause of death based on the National Death Index. We used multivariable regression models to estimate hazard ratios (HRs) per decade and by key treatment exposures. RESULTS HL survivors were of a mean age of 35.6 years (range, 12-58 years). The cumulative incidence of any grade 3-5 condition by 35 years of age was 31.4% (95% CI, 29.2 to 33.5). Females were twice as likely (HR, 2.1; 95% CI, 1.8 to 2.4) to have a grade 3-5 condition compared with males. From the 1970s to the 1990s, there was a 20% reduction (HR, 0.8; 95% CI, 0.7 to 0.9) in decade-specific risk of a grade 3-5 condition ( P trend = .002). In survivors who had a recurrence and/or hematopoietic cell transplant, the risk of a grade 3-5 condition was substantially elevated, similar to that of survivors treated with high-dose, extended-field radiotherapy (HR, 1.2; 95% CI, 0.9 to 1.5). Compared with survivors treated with chest radiotherapy ≥ 35 Gy in combination with an anthracycline or alkylator, a contemporary regimen for low-intermediate risk HL was estimated to lead to a 40% reduction in risk of a grade 3-5 condition (HR, 0.6; 95% CI, 0.4 to 0.8). CONCLUSION This study demonstrates that risk-adapted therapy for pediatric HL has resulted in a significant reduction in serious long-term outcomes." @default.
• W3132415718 created "2021-03-01" @default.
• W3132415718 creator A5002120651 @default.
• W3132415718 creator A5016016418 @default.
• W3132415718 creator A5020052772 @default.
• W3132415718 creator A5026141900 @default.
• W3132415718 creator A5036356438 @default.
• W3132415718 creator A5038361086 @default.
• W3132415718 creator A5039048640 @default.
• W3132415718 creator A5059262359 @default.
• W3132415718 creator A5063077038 @default.
• W3132415718 creator A5063521126 @default.
• W3132415718 creator A5065383236 @default.
• W3132415718 creator A5065573166 @default.
• W3132415718 creator A5071526115 @default.
• W3132415718 creator A5074725191 @default.
• W3132415718 creator A5078465445 @default.
• W3132415718 creator A5079552409 @default.
• W3132415718 creator A5089743648 @default.
• W3132415718 date "2021-07-10" @default.
• W3132415718 modified "2023-10-14" @default.
• W3132415718 title "Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study" @default.
• W3132415718 cites W1839076539 @default.
• W3132415718 cites W1894979576 @default.
• W3132415718 cites W1935834387 @default.
• W3132415718 cites W1955391915 @default.
• W3132415718 cites W1975846828 @default.
• W3132415718 cites W1977198369 @default.
• W3132415718 cites W1983317938 @default.
• W3132415718 cites W1998233750 @default.
• W3132415718 cites W2000437372 @default.
• W3132415718 cites W2004799731 @default.
• W3132415718 cites W2014432477 @default.
• W3132415718 cites W2015323651 @default.
• W3132415718 cites W2015758016 @default.
• W3132415718 cites W2018538091 @default.
• W3132415718 cites W2024136031 @default.
• W3132415718 cites W2026984356 @default.
• W3132415718 cites W2029275609 @default.
• W3132415718 cites W2030662776 @default.
• W3132415718 cites W2037066552 @default.
• W3132415718 cites W2045627979 @default.
• W3132415718 cites W2057260087 @default.
• W3132415718 cites W2058217833 @default.
• W3132415718 cites W2062010938 @default.
• W3132415718 cites W2064986772 @default.
• W3132415718 cites W2066617715 @default.
• W3132415718 cites W2094526171 @default.
• W3132415718 cites W2101807916 @default.
• W3132415718 cites W2103004443 @default.
• W3132415718 cites W2105900079 @default.
• W3132415718 cites W2108513094 @default.
• W3132415718 cites W2108539626 @default.
• W3132415718 cites W2109831529 @default.
• W3132415718 cites W2113796718 @default.
• W3132415718 cites W2114738305 @default.
• W3132415718 cites W2128719630 @default.
• W3132415718 cites W2128937521 @default.
• W3132415718 cites W2128975535 @default.
• W3132415718 cites W2131158841 @default.
• W3132415718 cites W2137336819 @default.
• W3132415718 cites W2141687454 @default.
• W3132415718 cites W2143608188 @default.
• W3132415718 cites W2144410376 @default.
• W3132415718 cites W2150719401 @default.
• W3132415718 cites W2152710213 @default.
• W3132415718 cites W2155353212 @default.
• W3132415718 cites W2257132615 @default.
• W3132415718 cites W2321358810 @default.
• W3132415718 cites W2498753998 @default.
• W3132415718 cites W2752414510 @default.
• W3132415718 cites W2803022920 @default.
• W3132415718 cites W2808182931 @default.
• W3132415718 cites W2892089040 @default.
• W3132415718 cites W2900348927 @default.
• W3132415718 cites W2906940684 @default.
• W3132415718 cites W2913869848 @default.
• W3132415718 cites W2954161574 @default.
• W3132415718 doi "https://doi.org/10.1200/jco.20.01186" @default.
• W3132415718 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8260906" @default.
• W3132415718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33630659" @default.
• W3132415718 hasPublicationYear "2021" @default.
• W3132415718 type Work @default.
• W3132415718 sameAs 3132415718 @default.
• W3132415718 citedByCount "16" @default.
• W3132415718 countsByYear W31324157182021 @default.
• W3132415718 countsByYear W31324157182022 @default.
• W3132415718 countsByYear W31324157182023 @default.
• W3132415718 crossrefType "journal-article" @default.
• W3132415718 hasAuthorship W3132415718A5002120651 @default.
• W3132415718 hasAuthorship W3132415718A5016016418 @default.
• W3132415718 hasAuthorship W3132415718A5020052772 @default.
• W3132415718 hasAuthorship W3132415718A5026141900 @default.
• W3132415718 hasAuthorship W3132415718A5036356438 @default.
• W3132415718 hasAuthorship W3132415718A5038361086 @default.
• W3132415718 hasAuthorship W3132415718A5039048640 @default.
• W3132415718 hasAuthorship W3132415718A5059262359 @default.
• W3132415718 hasAuthorship W3132415718A5063077038 @default.

• next